Ziccum AB
ZICC | FN
Overview
Corporate Details
- ISIN(s):
- SE0011415595 (+3 more)
- LEI:
- 5493005TADJBZHXP0U27
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Ziccum AB develops dry-powder versions of biologics and vaccines. Their technology facilitates easier storage and distribution of medical products.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-13 | Ann Gidner | Other | Buy | 14,000 | 8,381.80 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN |